Skip to main content
Premium Trial:

Request an Annual Quote

Guava CEO Rajen Dalal Resigns; Chairman John Walker Takes Over

NEW YORK, Feb. 1 (GenomeWeb News) - Guava Technologies President and CEO Rajen Dalal has resigned, the Hayward, Calif.-based company said today. John Walker, the chairman of Guava's board of directors, has taken over the company as interim CEO.

 

No information about the reason for Dalal's resignation was immediately available from the company.

 

In addition to his involvement with Guava, Walkeris an investment advisor to MDS Capital and a vice chairman for biotechnology company Renovis. He is also a director of Discovery Partners International, Geron, and KAI Pharmaceuticals.

 

In the past, Walkerwas CEO of KAI Pharmaceuticals, Bayhill Therapeutics, Centaur Pharmaceuticals, and Axys Pharmaceuticals.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.